TABLE 1

Clinical characteristics of the study subjects

CADType 1 diabetic subjectsType 2 diabetic subjectsControl subjects
n1761814
Age60 ± 10*49 ± 1262 ± 10*49 ± 7
BMI (kg/m2)26.5 ± 2.427.3 ± 6.726.3 ± 2.825.3 ± 2.3
RPP (mmHg · bpm−1 · 10−3)8.6 ± 2.58.2 ± 0.88.5 ± 1.88.2 ± 1.1
Ejection fraction (%)35 ± 11*48 ± 2749 ± 1661 ± 10
FPG (mmol/l)5.7 ± 0.710.8 ± 3.9*8.9 ± 3.8*4.9 ± 0.7
Clamp [G] (mmol/l)5.4 ± 0.75.9 ± 0.65.9 ± 1.35.2 ± 0.9
  • RPP, rate-pressure product; FPG, fasting plasma glucose concentration; clamp [G], steady-state glucose concentration during the insulin clamp.

  • *

    * P < 0.05 or less vs. control subjects.